Loading...
Metabolic Reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer
Androgen deprivation therapy (ADT) is standard-of-care for advanced-stage prostate cancer, and enzalutamide (Xtandi(®), Astellas, Northbrook, IL, USA), a second generation antiandrogen, is prescribed in this clinical setting. The response to this medication is usually temporary with the rapid emerge...
Saved in:
| Published in: | Cells |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7759897/ https://ncbi.nlm.nih.gov/pubmed/33255236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9122535 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|